Neurocrine Bioscience and Acadia Pharmaceuticals posted positive top-line results from their respective Phase III trials on major neurological diseases.
If you are not happy with the results below please do another search
50 search results for:
Americans are lining up for booster doses of Covid-19 vaccines at a record pace, with concerns about the newly detected Omicron coronavirus variant spurring millions to get shots, the U.S. government said on December 7.
The Omicron variant can partially evade protection from two doses of Pfizer and partner BioNTech’s Covid-19 vaccine, the research head of a laboratory at the Africa Health Research Institute in South Africa said on December 7.
The Omicron variant has been reported in 57 nations and the number of patients needing hospitalization is likely to rise as it spreads, the World Health Organization said on December 8.
Theranos founder Elizabeth Holmes denied making misleading statements about the blood-testing startup during cross-examination on December 7, as her testimony in defense against fraud charges neared its end.
Carlsbad, Calif.-based Ionis Pharmaceuticals inked a collaboration deal with AstraZeneca to develop and commercialize eplontersen for transthyretin amyloidosis (ATTR).
New Mexico agreed to join a proposed nationwide settlement worth up to $21 billion resolving claims that the three largest U.S. drug distributors fueled a deadly opioid epidemic, the state’s attorney general said on December 7.
The World Health Organization updated its guidelines for COVID-19 treatments against the use of convalescent plasma for all cases of infection.
The U.S. Federal Trade Commission and seven states on December 7 settled claims accusing Vyera Pharmaceuticals of trying to block generic versions of the company’s life-saving drug Daraprim, but are preparing for a Dec. 14 trial against accused mastermind Martin Shkreli.
The shares of Utah-based Recursion climbed on December 7 after the company announced entering into a “transformational collaboration” with Swiss pharma giant Roche valued in the billions of dollars to identify and develop up to 40 new medications for neuroscience and oncology.